|
You are here |
www.medicare.gov | ||
| | | | |
aspe.hhs.gov
|
|
| | | | | The National Alzheimer's Project Act (NAPA) creates an important opportunity to build upon and leverage HHS programs and other federal efforts to help change the trajectory of Alzheimer's disease and related dementias (AD/ADRD). The law calls for a National Plan for AD/ADRD with input from a public-private Advisory Council on Alzheimer's Research, Care and Services. The Advisory Council makes recommendations to HHS for priority actions to expand, coordinate, and condense programs in order to improve the ... | |
| | | | |
ktinboulder.com
|
|
| | | | | One of my favorite stories from my time in Washington, D.C. came from a dedicated civil servant who became one of my closest friends and colleagues at the Centers for Medicare and Medicaid. With a background in public health and a passion to help people, she joined CMS 25 years ago. Over time, the policies... | |
| | | | |
www.samhsa.gov
|
|
| | | | | SAMHSA's National Helpline is a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for individuals and families facing mental and/or substance use disorders. | |
| | | | |
aspe.hhs.gov
|
|
| | | Insulin prices have increased dramatically over the past decade in the United States. This report presents results from international price comparisons of insulins using a price index approach. The average gross manufacturer price for a standard unit of insulin in 2018 was more than ten times the price in a sample of 32 foreign countries:$98.70 in the U.S., compared with $8.81 in the 32 non-U.S. OECD countries for which we have prescription drug data. The U.S. prices for the mix of insulin used in the U.... | ||